PAP 2023: Diana Villanova Discusses Experience in Biotech Consulting with Current Role

A cross-sectional study uncovers the current and projected economic burden of Alzheimer’s disease and related dementias (ADRD) through 2060 among non-Latino African American, Latino, and non-Latino White adults.

Renier Brentjens, MD, PhD outlines the evolution of the space, while offering ways to boost patient access to these treatments.

In an effort to greater prepare HCPs and to avoid potential shortages, the company targets Q3 as the shipment date.

Brandon Newman joins The Pharmaceutical Commerce Podcast to discuss the evolving role of PBMs, including the importance of drug price transparency.

A cross-sectional study explores how full-benefit dual-eligible beneficiaries differ across MA plans with differing levels of Medicaid coordination and integration.

Direct-to-consumer and direct-to-patient models are major contributors.